ArticleMolecular cancer research : MCR2023

Fibronectin Contributes to a BRAF Inhibitor-driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2.

Hannah M Hicks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.